1.
Am J Infect Control
; 2024 Jul 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-39053513
RESUMO
As a newly emerging pathogen, infection prevention and isolation management response for SARS-CoV-2 varied greatly by individual health care center. Specific patient population needs, especially those of severely immunocompromised oncologic patients, potentially intensified the response. A survey was distributed to academic health care centers to ascertain surveillance testing frequency, patient placement, and isolation management for patients undergoing cell therapy treatments.